Structure-Activity Relationships and Antiproliferative Effects of 1,2,3,4-4H-Quinoxaline Derivatives as Tubulin Polymerization Inhibitors

2021 ◽  
pp. 104793
Author(s):  
Tingting Liang ◽  
Xiaomin Zhou ◽  
Lu Lu ◽  
Haiyang Dong ◽  
Yanan Zhang ◽  
...  
2005 ◽  
Vol 15 (23) ◽  
pp. 5154-5159 ◽  
Author(s):  
Xiaohu Ouyang ◽  
Xiaoling Chen ◽  
Evgueni L. Piatnitski ◽  
Alexander S. Kiselyov ◽  
Hai-Ying He ◽  
...  

2019 ◽  
Vol 16 (9) ◽  
pp. 1069-1073
Author(s):  
Zhongping Li ◽  
Lingling Ma ◽  
Chengyong Wu ◽  
Tao Meng ◽  
Lanping Ma ◽  
...  

Background: Drugs that interfere with microtubule dynamics are used widely in cancer chemotherapy. Microtubules are composed of αβ-tubulin heterodimers, and the colchicine binding site of tubulin is an important pocket for designing tubulin polymerization inhibitors. We have previously designed and synthesized a series of colchicine binding site inhibitors (CBSIs). However, these compounds showed no anticancer activity in vivo. Then, we have used a deconstruction approach to obtain a new derivative MT189, which showed in vivo anticancer activity. Methods: We crystallized a protein complex including two tubulins, one stathmin-like domain of RB3 and one tubulin tyrosine ligase, and soaked MT189 into the crystals. We collected the diffraction data and determined the tubulin-MT189 structure to 2.8 Å. Results: Here, we report the crystal structure of tubulin complexed with MT189, elucidate how the small-molecular agent binds to tubulin and inhibits microtubule assembly, and explain previous results of the structure-activity-relationship studies. Conclusion: The tubulin-MT189 complex structure reveals the interactions between this agent and tubulin and provides insights into the design of new derivatives targeting the colchicine binding site.


2013 ◽  
Vol 4 (7) ◽  
pp. 596-600 ◽  
Author(s):  
Masashi Yoshimura ◽  
Masahiro Ono ◽  
Kenji Matsumura ◽  
Hiroyuki Watanabe ◽  
Hiroyuki Kimura ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document